Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gerakari, Styliani
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23
REACT, NCT06294600: Clarithromycin Treatment to Prevent Sepsis Progression in CAP	Recruiting	3	330	Europe	Clarithromycin 500mg, A β-lactam/β-lactamase inhibitor or a 3rd generation cephalosporin or a fluoroquinolone, Tablets	Hellenic Institute for the Study of Sepsis	Community-acquired Pneumonia	11/25	01/26
PRECISION, NCT05926505 / 2023-000102-25: Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome	Recruiting	2/3	182	Europe	Placebo, Anakinra 149 MG/ML Prefilled Syringe [Kineret]	Hellenic Institute for the Study of Sepsis, Hellenic Institute for the Study of Sepsis	Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID	08/25	08/25
CRONUS, NCT05897801: Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO	Completed	N/A	230	Europe	MeMed BV®	Hellenic Institute for the Study of Sepsis	Viral Infection, Bacterial Infections, Multi-antibiotic Resistance, Respiratory Tract Infections	12/23	01/24